.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
US Department of Justice
Mallinckrodt
UBS
Queensland Health
Farmers Insurance
McKesson
Chubb
Chinese Patent Office
Daiichi Sankyo

Generated: September 23, 2017

DrugPatentWatch Database Preview

NPH PURIFIED PORK ISOPHANE INSULIN Drug Profile

« Back to Dashboard

What is the patent landscape for Nph Purified Pork Isophane Insulin, and what generic Nph Purified Pork Isophane Insulin alternatives are available?

Nph Purified Pork Isophane Insulin is a drug marketed by Novo Nordisk Inc and is included in one NDA.

The generic ingredient in NPH PURIFIED PORK ISOPHANE INSULIN is insulin susp isophane purified pork. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin susp isophane purified pork profile page.

Summary for Tradename: NPH PURIFIED PORK ISOPHANE INSULIN

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list4,269
Drug Prices:see details
DailyMed Link:NPH PURIFIED PORK ISOPHANE INSULIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
NPH PURIFIED PORK ISOPHANE INSULIN
insulin susp isophane purified pork
INJECTABLE;INJECTION018623-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Baxter
Accenture
US Department of Justice
Deloitte
Merck
UBS
Federal Trade Commission
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot